Denali Therapeutics Reports First Quarter 2024 Financial Results and Business Highlights

Go back to Denali Therapeutics Reports First Quarter 2024 Financial Results and Business Highlights
(NASDAQ: DNLI) Delayed: 24.82 +0.05 (0.20%)
Previous Close $24.77    52 Week High
Open $25.14    52 Week Low
Day High $25.69    P/E N/A 
Day Low $24.72    EPS
Volume 1,493,719